Ümmühan Tuğba Tümüklü

Ümmühan Tuğba Tümüklü

Auto-generated profile, based on publicly available information

Ümmühan Tuğba Tümüklü

Yozgat Bozok Üniversitesi

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2025 in Journal of Pulmonology and Intensive Care
Verified
Journal Article
Open access
PDF file
ÜTÜmmühan Tuğba Tümüklü
Ümmühan Tuğba Tümüklü
DFDUYGU FELEK
DUYGU FELEK
Aims: Although pneumonia is typically considered a localized infection, it can trigger a systemic inflammatory response. Systemic inflammation is characterized by cytokine release throughout the body, increased acute phase reactants, and immune cell imbalance, which can elevate disease severity and the risk of complications. Recently, hematological parameters such as the systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI) have gained prominence in assessing this inflammatory response. This study aimed to evaluate systemic inflammation levels in patients diagnosed with pneumonia using SII and SIRI, and to analyze their correlation with classical inflammatory biomarkers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Methods: A total of 50 patients hospitalized and followed up with a diagnosis of pneumonia between 01.01.2023 and 01.06.2025 at Yozgat Bozok University Research and Training Hospital's Departments of Pulmonology and Internal Medicine, and 50 healthy individuals admitted to the same clinics during the same period were included in the study. Demographic data (age, gender), smoking status, clinical histories, laboratory values, treatment processes, complete blood count (CBC), CRP level, and ESR were recorded. Patients with active malignancy, hematological or autoimmune diseases, or those under immunosuppressive therapy were excluded. SII and SIRI values were calculated for each participant. Results: Of the participants, 66% were male and 34% female, with a mean age of 61.98 ± 16.78 years in the pneumonia group and 59.20 ± 16.10 years in the control group. SII was significantly higher in the pneumonia group (1301.28 ± 886.78) compared to the control group (545.20 ± 488.26), as was SIRI (5.66 ± 6.58 vs. 0.91 ± 1.21) (p<0.001 for both). Smokers exhibited significantly higher SII (1535.9 ± 1094.1 vs. 977.2 ± 560.3) and SIRI (7.51 ± 8.13 vs. 3.10 ± 3.72) values than non-smokers (p=0.031 and p=0.014, respectively). Conclusion: This study demonstrated that new-generation inflammation indices such as SII and SIRI reflect the intensity of inflammatory response in pneumonia patients and show significant correlation with CRP levels. These findings suggest that integrating these indices into clinical practice may serve as effective tools in evaluating disease prognosis and monitoring treatment response.

29 August 2025 in Intercontinental Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
ÜTÜmmühan Tuğba Tümüklü
Ümmühan Tuğba Tümüklü
ZSZehra Seyfikli
Zehra Seyfikli
Obstructive Sleep Apnea Syndrome (OSAS) is a significant health condition characterized by recurrent upper airway obstructions during sleep, with widespread systemic consequences. This review aims to present a comprehensive overview of OSAS, encompassing its pathophysiological foundations, risk factors, clinical manifestations, associated comorbidities, and contemporary diagnostic and therapeutic strategies. OSAS not only impairs sleep quality but also adversely affects cardiovascular, metabolic, neurocognitive, and psychological health, thereby reducing both lifespan and quality of life. While polysomnography remains the gold standard for diagnosis, home sleep tests and subjective assessment tools are increasingly utilized in clinical practice. Treatment approaches vary depending on disease severity and individual characteristics, ranging from lifestyle modifications and positive airway pressure devices to oral appliances and surgical interventions. In recent years, promising innovations such as neurostimulation and pharmacotherapy have emerged in OSAS management. This review highlights the multidimensional impact of OSAS at both individual and societal levels, emphasizing the need for early diagnosis and integrated treatment strategies.

29 May 2025 in Journal of Pulmonology and Intensive Care
Verified
Journal Article
Open access
PDF file
ÜTÜmmühan Tuğba Tümüklü
Ümmühan Tuğba Tümüklü
NÇNermin Çapan
Nermin Çapan
Aims: Asthma is a disease characterized by diffuse and reversible narrowing of the airways, affecting approximately 300 million people worldwide. Metabolic syndrome, on the other hand, is a fatal endocrinopathy that begins with insulin resistance. Numerous studies have investigated the impact of metabolic syndrome on airway inflammation in patients with asthma. In this study, we aimed to investigate the coexistence of metabolic syndrome in patients followed up with a diagnosis of asthma and its impact on asthma control using the asthma control test (ACT). Methods: A total of 50 patients, including 10 men and 40 women aged between 18 and 70 years, who presented to the asthma outpatient clinic of Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital and were diagnosed with asthma, were included in the study. Participants completed a questionnaire assessing demographic characteristics and medical history. Subsequently, height, weight, waist circumference, and triceps skinfold thickness measurements were taken. Arterial blood pressure was measured, and blood samples were collected after 12 hours of fasting to evaluate serum triglyceride (TG), HDL, and fasting glucose levels, along with a complete blood count. Pulmonary function tests were performed, and participants responded to the short form of the International Physical Activity Questionnaire (IPAQ). Results: Upon evaluation, 30% of the cases were diagnosed with metabolic syndrome. Metabolic syndrome was diagnosed in 40% of male and 27.5% of female patients. Among the 50 participants, 16 (32%) were diagnosed with obesity, 19 (38%) with hypertension, and 1 (2%) with diabetes mellitus. The average duration of asthma follow-up was calculated as 10.8±8.7 years. The prevalence of metabolic syndrome was found to be higher in postmenopausal women compared to premenopausal women, whereas among women using oral contraceptives, the diagnosis of metabolic syndrome was lower than in non-users; however, this was not statistically significant (p>0.05). However, waist circumference measurements were significantly higher in those with metabolic syndrome compared to those without (p<0.05). A significant association was found between serum TG levels and metabolic syndrome diagnosis, while no significant relationship was observed for fasting blood glucose and serum HDL levels. Both systolic and diastolic blood pressure values were found to be higher in individuals with metabolic syndrome, with a statistically significant association between blood pressure values and the diagnosis of metabolic syndrome. According to the ACT results, 4 patente (8%) were under control, 17 (34%) were partially controlled, and 29 (58%) were uncontrolled. Among patients with metabolic syndrome, the forced expiratory volume in 1 second (FEV1) was found to be lower with borderline values. No significant association was found between physical activity levels and metabolic syndrome. Both groups, with and without metabolic syndrome, had low ACT scores, and no significant relationship was found between metabolic syndrome and ACT scores. Conclusion: Nonetheless, based on the findings of this study, we believe that metabolic syndrome should also be considered when planning treatment for asthmatic patients.

15 December 2025 in Bozok Tıp Dergisi
Verified
Journal Article
Closed access
ÜTÜmmühan Tuğba Tümüklü
Ümmühan Tuğba Tümüklü
VTVugar Ali Turksoy
Vugar Ali Turksoy
ZSZehra Seyfikli
Zehra Seyfikli
Amaç: Bu çalışmanın amacı, Yozgat Bozok Üniversitesi Araştırma ve Uygulama Hastanesi cerrahi kliniklerinde hospitalize edilen hastalarda Obstrüktif Uyku Apne Sendromu (OUAS) prevalansını belirlemek ve bu bireylerin hastalık farkındalık düzeylerini değerlendirmektir. Elde edilecek veriler ile preoperatif dönemde uygulanacak sistematik tarama protokollerinin hasta güvenliği ve cerrahi sonuçlar üzerindeki etkisinin ortaya konması hedeflenmektedir. Gereç ve Yöntem: Bu çalışma, Yozgat Bozok Üniversitesi Hastanesi’nin cerrahi kliniklerinde 2024 yılı içerisinde yatırılarak tedavi edilen erişkin bireylerde yürütülen kesitsel, tanımlayıcı ve analitik bir araştırmadır. Çalışmaya 18 yaş üzeri, bilgilendirilmiş onam vermiş ve iletişim kurabilen hastalar dahil edilmiş; OUAS tanısı ile tedavi görmekte olanlar, bilişsel bozukluk veya akut psikiyatrik hastalığı olanlar çalışma dışında bırakılmıştır. Veriler, yüz yüze görüşmelerle yapılandırılmış anket formları ve Epworth Uykululuk Ölçeği kullanılarak toplanmış, pozitif tarama sonuçları polisomnografik değerlendirme için riskli kabul edilmiştir. Etik kurul onayı alınarak Helsinki Deklarasyonu ilkelerine uygun şekilde yürütülen araştırmanın verileri SPSS 20.0 programında analiz edilmiş, uygun parametrik ve non-parametrik testler kullanılmış ve istatistiksel anlamlılık düzeyi p

31 January 2026 in Archives of Current Medical Research
Verified
Journal Article
Closed access
IAİsMail Ağı
İsMail Ağı
CKCan Kerestecioğlu
Can Kerestecioğlu
ÜTÜmmühan Tuğba Tümüklü
Ümmühan Tuğba Tümüklü
SÇSelin Büşra Çakır
Selin Büşra Çakır
ZSZehra Seyfikli
Zehra Seyfikli
Background: This study aims to investigate the association between the Systemic Inflammatory Response Index (SIRI) and the Systemic Immune-Inflammation Index (SII) and serious cardiovascular diagnoses such as myocardial infarction, pulmonary thromboembolism, and aortic dissection in patients presenting to the emergency department with chest pain. Additionally, it evaluates the potential role of these biomarkers in supporting clinical decision-making processes. Methods: This retrospective cross-sectional study included 612 patients aged 18–100 years who presented with chest pain to the Emergency Department of Yozgat City Hospital between July 1, 2025, and July 31, 2025. Demographic characteristics, final diagnoses, and laboratory parameters were analyzed, and SII and SIRI values were calculated accordingly. Statistical analyses were conducted using SPSS 22 with appropriate statistical tests. Results: In the STEMI group, the mean SII was 1725.90 ± 1274.25 and the mean SIRI was 4.50 ± 3.66. In the NSTEMI group, these values were 1410.94 ± 1341.51 and 3.28 ± 2.79, respectively. Patients with non-cardiovascular causes exhibited significantly lower SII and SIRI levels. Based on ROC analysis, the AUC for SII was 0.738 with a cut-off value of 658, while the AUC for SIRI was 0.723 with a cut-off of 1.92. A positive and significant correlation was found between SII/SIRI and troponin and D-dimer levels (p < 0.001). Conclusion: SII and SIRI levels are markedly elevated in chest pain of cardiovascular origin and may serve as useful adjunct biomarkers in the diagnostic differentiation of these conditions.

15 October 2025 in Journal of Radiology in Medicine
Verified
Journal Article
Open access
PDF file
CKCan Kerestecioğlu
Can Kerestecioğlu
ÜTÜmmühan Tuğba Tümüklü
Ümmühan Tuğba Tümüklü
DFDUYGU FELEK
DUYGU FELEK
MEMustafa Fatih Erkoç
Mustafa Fatih Erkoç
Aims: This study aims to radiologically evaluate the impact of chronic obstructive pulmonary disease (COPD) on the diameter of the ascending aorta (AsAo) in individuals diagnosed with hypertension and to explore the potential structural effects of COPD on the cardiovascular system. Methods: This retrospective cross-sectional study was conducted at Yozgat Bozok University Research and Training Hospital. Clinical and radiological data of 60 hypertensive individuals who underwent thoracic computed tomography (CT) between January 1, 2023, and June 1, 2025, were analyzed. Participants were divided into two groups based on the presence or absence of a COPD diagnosis. Ascending aorta and aortic arch (Arcus Ao) diameters were measured from CT images. Clinical variables, comorbidities, and lipid profiles were statistically evaluated. Results: The mean age of participants was significantly higher in the COPD group (73.8 ± 7.92 years) compared to the control group (67.93 ± 12.59 years) (p = 0.036). The mean AsAo diameter was 40.40 ± 4.90 mm in the COPD group and 36.01 ± 3.79 mm in the control group, revealing a statistically significant difference (p = 0.00028). No significant difference was found between the groups regarding Arcus Ao diameter (p = 0.103). Among lipid parameters, there were no significant differences in HDL, LDL, or total cholesterol levels; however, triglyceride levels approached statistical significance (p = 0.069). Conclusion: The findings suggest that COPD is not merely a respiratory condition but also a systemic disease with notable vascular implications. The significant increase in AsAo diameter in the COPD group may be attributed to chronic inflammation, endothelial dysfunction, and degeneration of elastic fibers associated with the disease. The absence of a significant difference in Arcus Ao diameter may be related to the anatomically stable structure of this segment. The higher comorbidity burden and older age observed in COPD patients further support the systemic nature of the disease.